140 filings
Page 5 of 7
8-K
z7uj9php6785uoqflt
6 Jun 17
Regulation FD Disclosure
12:00am
8-K
mo01 tiydvh7hr
21 Feb 17
Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering
12:00am
8-K
olz1c 6l70qq
16 Feb 17
Other Events
12:00am
8-K
k5u9wfpxb pqmk3zne
2 Feb 17
Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics
12:00am
8-K
6j6y1 n6r
31 Oct 16
Other Events
12:00am
8-K
uyfrylne0ztenciu6s
29 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
kv672obwo3c6v1fu3l
15 Aug 16
Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
12:00am
8-K
4d76c7z
6 Jun 16
Arch Therapeutics Completes Patient Enrollment in Clinical Study of AC5
12:00am
8-K
cz5htga0ofnh ohh
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
say fui9v8
16 May 16
Arch Therapeutics Announces Issuance of Composition of Matter Patent Covering Self-Assembling Peptidomimetics
12:00am
8-K
jdyd shwor6p
10 May 16
Arch Therapeutics Receives Notice of Allowance for Composition of Matter and Method of Use Patent Covering Solid Forms of Self-Assembling Peptides
12:00am
8-K
kis80z3o
6 May 16
Unregistered Sales of Equity Securities
12:00am
8-K
ortewmubqg7 vqzl3ca
25 Apr 16
Arch Therapeutics Receives Notice of Allowance for Patent Covering Systemic Applications for Self-Assembling Peptides
12:00am
8-K
avfbd18ohgkuh0pvq6t
11 Apr 16
Arch Therapeutics Announces Notice of Allowance for Method of Use Patent Covering Uses of Self-Assembling Peptides
12:00am
8-K
okvz1n02iagb8r1iz
5 Apr 16
Arch Therapeutics Announces Notice of Allowance for Composition-of-Matter Patent Covering Self-Assembling Peptides
12:00am
8-K
lc8k0lp3daltfjx3
22 Mar 16
Other Events
12:00am
8-K
wi2p pvn54
14 Mar 16
Arch Therapeutics Reports Favorable Results for AC5 Surgical Hemostatic Device in Biocompatibility Testing Required for CE Mark
12:00am
8-K
93tgzr2l42lim xx3
9 Mar 16
Arch Therapeutics Receives ISO 13485 Certification for AC5
12:00am
8-K
tpbd8ckd
7 Mar 16
Other Events
12:00am
8-K
eec z7d4zrabncwddvw
16 Dec 15
Arch Therapeutics Receives Clearance to Initiate Clinical Trial in Europe
12:00am